Literature DB >> 31438772

MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1.

Yanling Ma1, Fei Yan1, Wujie Wei1, Jie Deng1, Li Li1, Li Liu1, Jianhai Sun1.   

Abstract

Emerging evidence has identified the critical role of microRNAs in gastric cancer (GC). Herein, this study intends to characterize the tumor suppressive role of microRNA-598 (miR-598) in GC stem-like cells, with the involvement of RRS1. The CD133+ GC stem-like cells were sorted by flow cytometry, after which immunofluorescence assay was used to determine the co-localization of CD133 and CD44v8-10. The miR-598 expression was examined in the CD133+ and CD133- cells. Subsequently, the CD133+ cells were subjected to miR-598 mimics, miR-598 inhibitors or RRS1 siRNA to validate the effect of miR-598 on GC stem-like cell proliferation, colony formation, apoptosis, migration and invasion capacities. Besides, the effect of miR-598 on the expression of key factors (OCT4, SOX2 and NANOG) associated with stem cell characteristics was measured. The obtained results indicated that the sphere forming capacity was higher in CD133+ cells. CD133+ MKN-45 cells expressed CD133 and CD44v8-10, and were expressed on the cell membrane. MiR-598 was poorly expressed in CD133+ cells. Notably, miR-598 negatively regulated RRS1. In response to miR-598 mimics and RRS1 siRNA, the MKN-45 cells displayed inhibited proliferation, colony formation, migration and invasion, accompanied by elevated apoptosis. Besides, the miR-598 inhibitors reversed the situation. This study highlights that miR-598 a tumor suppressor in GC stem-like cells by inhibiting RRS1, whereby miR-598 represses MKN-45 cell growth and invasion by attenuating self-renewal of GC stem-like cells.

Entities:  

Keywords:  Gastric cancer stem-like cell; MicroRNA-598; RRS1; Self-renewal; cancer stem cell

Mesh:

Substances:

Year:  2019        PMID: 31438772      PMCID: PMC6773227          DOI: 10.1080/15384101.2019.1657338

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  41 in total

1.  Serum expression levels of microRNA-382-3p, -598-3p, -1246 and -184 in breast cancer patients.

Authors:  Lun Fu; Zhaoyun Li; Jie Zhu; Pan Wang; Guangmin Fan; Yuechu Dai; Zhibao Zheng; Yang Liu
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

Review 2.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

3.  A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis.

Authors:  Ziqiang Zhang; Yuanqiang Dong; Jin Hua; Hongyuan Xue; Jian Hu; Tao Jiang; Liubin Shi; Jianjun Du
Journal:  Gene       Date:  2019-03-05       Impact factor: 3.688

4.  Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease.

Authors:  Alisia Carnemolla; Elisa Fossale; Elena Agostoni; Silvia Michelazzi; Raffaella Calligaris; Luca De Maso; Giannino Del Sal; Marcy E MacDonald; Francesca Persichetti
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

5.  MiR-598: A tumor suppressor with biomarker significance in osteosarcoma.

Authors:  Kai Liu; Xiaolu Sun; Yingang Zhang; Liang Liu; Qiling Yuan
Journal:  Life Sci       Date:  2017-09-04       Impact factor: 5.037

6.  Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.

Authors:  Qing Ji; Xinbao Hao; Yang Meng; Min Zhang; Jeffrey Desano; Daiming Fan; Liang Xu
Journal:  BMC Cancer       Date:  2008-09-21       Impact factor: 4.430

7.  RRS1 silencing suppresses colorectal cancer cell proliferation and tumorigenesis by inhibiting G2/M progression and angiogenesis.

Authors:  Xin-Lin Wu; Zhi-Wen Yang; Li He; Pei-De Dong; Ming-Xing Hou; Xing-Kai Meng; Hai-Ping Zhao; Zhao-Yang Wang; Feng Wang; Yong-Feng Jia; Lin Shi
Journal:  Oncotarget       Date:  2017-09-15

8.  MiR-92 suppresses proliferation and induces apoptosis by targeting EP4/Notch1 axis in gastric cancer.

Authors:  Vivian Yvonne Shin; Man-Ting Siu; Xin Liu; Enders K O Ng; Ava Kwong; Kent-Man Chu
Journal:  Oncotarget       Date:  2018-05-11

9.  miR-598 acts as a tumor suppressor in human gastric cancer by targeting IGF-1R.

Authors:  Na Liu; Hua Yang; Hong Wang
Journal:  Onco Targets Ther       Date:  2018-05-17       Impact factor: 4.147

Review 10.  Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches.

Authors:  Yan Fu; Peizhun Du; Jing Zhao; Cheng'en Hu; Yunyun Qin; Guangjian Huang
Journal:  Yonsei Med J       Date:  2018-12       Impact factor: 2.759

View more
  11 in total

Review 1.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

Review 2.  Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy.

Authors:  Fang Huang; Chuanjing Dai; Youni Zhang; Yuqi Zhao; Yigang Wang; Guoqing Ru
Journal:  Front Mol Biosci       Date:  2022-07-04

3.  Scouting for common genes in the heterogenous hypoxic tumor microenvironment and their validation in glioblastoma.

Authors:  Ashish Bhushan; Ranbala Kumari; Tapasya Srivastava
Journal:  3 Biotech       Date:  2021-09-26       Impact factor: 2.893

4.  Low-dose Diosbulbin-B (DB) activates tumor-intrinsic PD-L1/NLRP3 signaling pathway mediated pyroptotic cell death to increase cisplatin-sensitivity in gastric cancer (GC).

Authors:  Chunfeng Li; Junqiang Qiu; Yingwei Xue
Journal:  Cell Biosci       Date:  2021-02-12       Impact factor: 7.133

5.  MicroRNA-598 inhibits the growth of triple negative breast cancer cells by targeting JAG1.

Authors:  Guohui Han; Xiangdong Bai; Hongchuan Jiang; Qiang He
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

Review 6.  Advances in the Relationship Between Regulator of Ribosome Synthesis 1 (RRS1) and Diseases.

Authors:  Yanan Hua; Jinlian Song; Cuixiu Peng; Runze Wang; Zhongliang Ma; Jinyu Zhang; Zheng Zhang; Ning Li; Lin Hou
Journal:  Front Cell Dev Biol       Date:  2021-02-25

7.  Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma.

Authors:  Xuewei Qi; Zeyu Liu; Qiaoli Zhang; Ming Yang; Yuxiang Wan; Jinchang Huang; Lin Xu
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

8.  Downregulated RRS1 inhibits invasion and metastasis of BT549 through RPL11‑c‑Myc‑SNAIL axis.

Authors:  Runze Wang; Cuixiu Peng; Junying Song; Yanan Hua; Qinglan Wu; Lin Deng; Yi Cao; Jinyu Zhang; Li Zhang; Li Wu; Lin Hou
Journal:  Int J Oncol       Date:  2022-02-18       Impact factor: 5.650

9.  Antitumor Effect of Si-Jun-Zi Decoction on SGC7901 Gastric Cancer Cells by CMTM2 Activation.

Authors:  Xiangnan Li; Wenna Chen; Lanying Miao; Hongwei Sun; Xia Gao; Shengnan Guo; Yueshi Zhang; Yufeng Yang; Junfu Guo
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-14       Impact factor: 2.650

10.  Circ_0007580 knockdown strengthens the radiosensitivity of non-small cell lung cancer via the miR-598-dependent regulation of THBS2.

Authors:  Zheng Yang; Hongfang Wu; Kai Zhang; Shilei Rao; Shuran Qi; Manxiang Liu; Ying Chen; Yang Wang
Journal:  Thorac Cancer       Date:  2022-01-19       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.